Hypera (OTCMKTS:HYPMY) Stock Price Crosses Above Fifty Day Moving Average – Should You Sell?
by Kim Johansen · The Markets DailyHypera S.A. (OTCMKTS:HYPMY – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.24 and traded as high as $3.68. Hypera shares last traded at $3.68, with a volume of 178 shares traded.
Hypera Stock Performance
The company has a debt-to-equity ratio of 0.68, a current ratio of 1.81 and a quick ratio of 1.41. The firm’s 50-day simple moving average is $3.25 and its 200 day simple moving average is $3.75.
Hypera Company Profile
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
- Five stocks we like better than Hypera
- Golden Cross Stocks: Pattern, Examples and Charts
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Stock Analyst Ratings and Canadian Analyst Ratings
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- What Makes a Stock a Good Dividend Stock?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play